InfuSystem Holdings, Inc. ( (INFU) ) has released its Q2 earnings. Here is a breakdown of the information InfuSystem Holdings, Inc. presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
InfuSystem Holdings, Inc. is a national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers, operating primarily in the Patient Services and Device Solutions sectors. In its second quarter of 2025, InfuSystem reported record net revenues of $36.0 million, marking a 7% growth from the previous year, alongside a significant increase in net income by 262% to $2.6 million. The company also achieved an adjusted EBITDA of $8.0 million, reflecting a 32% rise, and expanded its EBITDA margin to 22.3%. Key financial highlights include a 6% increase in Patient Services revenue and an 8% rise in Device Solutions revenue, driven by strategic investments and operational efficiencies. The company also repurchased $3.5 million in stock, enhancing shareholder value. Looking ahead, InfuSystem is focusing on expanding margins and improving profitability, with an updated revenue growth outlook of 6-8% for 2025, while aiming for an adjusted EBITDA margin of 20% or higher. The company remains committed to disciplined execution and long-term value creation for its shareholders.